Fideuram Asset Management (Ireland)’s Ionis Pharmaceuticals IONS Stock Holding History

Fideuram Asset Management (Ireland)’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$182K	Buy	+2,213	New	+$175K	0.02%	326

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fideuram Asset Management (Ireland)'s IONS Position: Q1 2026 in Review

Fideuram Asset Management (Ireland) opened a new position in Ionis Pharmaceuticals (IONS) in Q1 2026: 2,213 shares worth $182K. The stake represents 0.02% of the portfolio and ranks #326 among its holdings.

493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

Fideuram Asset Management (Ireland) held 2,213 shares of Ionis Pharmaceuticals worth $182K as of Q1 2026.
Ionis Pharmaceuticals was a new Fideuram Asset Management (Ireland) position in Q1 2026.
Ionis Pharmaceuticals made up 0.02% of Fideuram Asset Management (Ireland)'s portfolio in Q1 2026, its #326 holding.
493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Fideuram Asset Management (Ireland)'s 13F filing for Q1 2026, filed 11 May 2026.